Belyntic logo
Belyntic logo

Belyntic

belyntic.com
belyntic.com · HQ: Berlin, Germany · Founded 2018 · Startup · New
HQ: Berlin, Germany · Founded 2018 · Startup · New
Vaccines
Cell & Gene Therapy
Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2018 Founded
Registers and programsofficial lists and records that name the company
Legal entity Belyntic GmbH its site
Registered 16 May 2018
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds fund
Investors in similar startupsfunds that back the companies most like this one
GV
backs Sonoma Biotherapeutics
8VC
backs Sonoma Biotherapeutics
Daphni
backs Neotis
LAV
backs Sonoma Biotherapeutics
Italian Angels for Growth
backs ALKemist Bio
Inkef
backs Draupnir Bio
Similar startupsby what they do, their industry and backers
Centauri Therapeutics LimitedSeries A $7.6M · 8 mo ago · Founded 2014
At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Pantherna TherapeuticsFounded 2017
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases…
Tellus TherapeuticsVenture round $16M · 3 yr ago · Founded 2018 · 51-200 employees
Transforming Care Within and Beyond the NICU. Tellus Therapeutics was founded on a singular mission: to bring hope and healing to the most…
VEROVACCiNESVenture round · 6 mo ago · Founded 2017 · 11-50 employees
22 January 2017 2017, Feb. 22-23: VEROVACCiNES selected as Emerging Company at ANIMAL HEALTH INVESTMENT Europe, London UK conference 2017.
Neotis
Immunotherapiesfor fibrotic disease. Neotis is designing therapies that direct the immune system to eliminate cells driving fibrotic…
ALKemist BioVenture round $7.5M · 2 yr ago · 11-50 employees
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…

Overview

Novel Immunotherapies For Vulnerable Patients. At Belyntic, we are developing new therapies that harness the power of the patients' own immune system.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
High-Tech GründerfondsVia a fund
516 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berlin Germany
HQ